International Journal on Minority and Group Rights. Том 10. 2003. С. 203-220
Radiopharmaceuticals Based on Somatostatin Analogs and Technetium-99m Radionuclide for Diagnosis of Neuroendocrine Tumors: a Literature Review
Introduction Somatostatin receptor imaging capabilities Radiopharmaceuticals based on somatostatin receptors agonists and technetium-99m Radiopharmaceuticals based on somatostatin receptors antagonists and technetium-99m Conclusion. © 2025, A.I. Burnazyan Federal Medical Biophysical Center. All rights reserved.
Авторы
Tishchenko V.K. , Vlasova O.P. , Ivanov S.A. , Kaprin A.D.
Номер выпуска
1
Язык
Russian
Страницы
93-101
Статус
Published
Ссылка
Том
70
Год
2025
Организации
- 1 A.F. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Centre, Obninsk, Russian Federation
- 2 National Medical Research Radiological Center, Moscow, Russian Federation
- 3 Рeoples Friendship University of Russia, Moscow, Russian Federation
- 4 P.A. Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Center, Moscow, Russian Federation
Ключевые слова
neuroendocrine tumors; radionuclide diagnosis; radiopharmaceuticals; somatostatin analogs; technetium-99m
Поделиться
Другие записи
Frontiers in Clinical Diabetes and Healthcare. Том 6. 2025.